[Hypersensitivity to levobunolol].
A case is described in which, following local application of glaucoma eye drops containing Levobunolol, a recurring allergic contact eczema with periocular localisation occurred. In the course of the epicutaneous allergy testing a positive reaction (crescendo-type) could be clearly demonstrated experimentally against both the eye drops and their active ingredient, levobunolol-hydrochloride, a beta-blocker (beta-sympatholyticum) out of the class of the aryloxypropylamines.
Schultheiss
E
E
D001762:Blepharitis / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D005141:Eyelid Diseases; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D002040:Levobunolol / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010328:Patch Tests
D009883:Ophthalmic Solutions; D002040:Levobunolol
Uberempfindlichkeit gegenüber Levobunolol.